发明名称 Laiaspektrilised 2-(asendatud amino)bensoksasoolsulfoonamiidid kui HIV proteaasi inhibiitorid, nende kasutamine, farmatseutiline kompositsioon ja meetod retroviiruse replikatsiooni inhibeerimiseks
摘要 The present invention concerns the compounds having the formula N-oxides, salts, stereoisomeric forms, racemic mixtures, prodrugs, esters and metabolites thereof, wherein R<SUB>1 </SUB>and R<SUB>8 </SUB>each are H, optionally substituted C<SUB>1-6</SUB>alkyl, C<SUB>2-6</SUB>alkenyl, C<SUB>3-7</SUB>cycloalkyl, aryl, Het<SUP>1</SUP>, Het<SUP>2</SUP>; R<SUB>1 </SUB>may also be a radical of formula (R<SUB>11a</SUB>R<SUB>11b</SUB>)NC(R<SUB>10a</SUB>R<SUB>10b</SUB>)CR<SUB>9</SUB>-; t is 0, 1 or 2; R<SUB>2 </SUB>is H or C<SUB>1-6</SUB>alkyl; L is -C(-O)-, -O-C(-O)-, -NR<SUB>8</SUB>-C(-O)-, -O-C<SUB>1-6</SUB>alkanediyl-C(-O)-, -NR<SUB>8</SUB>-C<SUB>1-6</SUB>alkanediyl-C(-O)-, -S(-O)<SUB>2</SUB>-, -O-S(-O)<SUB>2</SUB>-, -NR<SUB>8</SUB>-S(-O)<SUB>2</SUB>; R<SUB>3 </SUB>is C<SUB>1-6</SUB>alkyl, aryl, C<SUB>3-7</SUB>cycloalkyl, C<SUB>3-7</SUB>cycloalkylC<SUB>1-4</SUB>alkyl, or arylC<SUB>1-4</SUB>alkyl; R<SUB>4 </SUB>is H, C<SUB>1-4</SUB>alkylOC(-O), carboxyl, aminoC(-O), mono- or di(C<SUB>1-4</SUB>alkyl)aminoC(-O), C<SUB>3-7</SUB>cycloalkyl, C<SUB>2-6</SUB>alkenyl, C<SUB>2-6</SUB>alkynyl or optionally substituted C<SUB>1-6</SUB>alkyl; A is C<SUB>1-6</SUB>alkanediyl, -C(-O)-, -C(-S)-, -S(-O)<SUB>2</SUB>-, C<SUB>1-6</SUB>alkanediyl-C(-O)-, C<SUB>1-6</SUB>alkanediyl-C(-S)- or C<SUB>1-6</SUB>alkanediyl-S(-O)<SUB>2</SUB>-; R<SUB>5 </SUB>is H, OH, C<SUB>1-6</SUB>alkyl, Het<SUP>1</SUP>C<SUB>1-6</SUB>alkyl, Het<SUP>2</SUP>C<SUB>1-6</SUB>alkyl, optionally substituted aminoC<SUB>1-6</SUB>alkyl; R<SUB>6 </SUB>is C<SUB>1-6</SUB>alkylO, Het<SUP>1</SUP>, Het<SUP>1</SUP>O, Het<SUP>2</SUP>, Het<SUP>2</SUP>O, aryl, arylO, C<SUB>1-6</SUB>alkyloxycarbonylamino or amino; and in case -A- is other than C<SUB>1-6</SUB>alkanediyl then R<SUB>6 </SUB>may also be C<SUB>1-6</SUB>alkyl, Het<SUP>1</SUP>C<SUB>1-4</SUB>alkyl, Het<SUP>1</SUP>OC<SUB>1-4</SUB>alkyl, Het<SUP>2</SUP>C<SUB>1-4</SUB>alkyl, Het<SUP>2</SUP>OC<SUB>1-4</SUB>alkyl, arylC<SUB>1-4</SUB>alkyl, arylOC<SUB>1-4</SUB>alkyl or aminoC<SUB>1-4</SUB>alkyl; whereby each of the amino groups in the definition of R<SUB>6 </SUB>may optionally be substituted; -A-R<SUB>6 </SUB>is hydroxyC<SUB>1-6</SUB>alkyl; R<SUB>5 </SUB>and -A-R<SUB>6 </SUB>taken together with the nitrogen atom to which they are attached may also form Het<SUP>1 </SUP>or Het<SUP>2</SUP>. It further relates to their use as broadspectrum HIV protease inhibitors, processes for their preparation as well as pharmaceutical compositions and diagnostic kits comprising them. It also concerns combinations thereof with another anti-retroviral agent, and to their use in assays as reference compounds or as reagents.
申请公布号 EE200300494(A) 申请公布日期 2003.12.15
申请号 EE20030000494 申请日期 2002.04.09
申请人 TIBOTEC PHARMACEUTICALS LTD. 发明人 DOMINIQUE LOUIS NESTOR GHISLAIN SURLERAUX;SANDRINE MARIE HELENE VENDEVILLE;WIM GASTON VERSCHUEREN;MARIE-PIERRE T.M.M.G DE BETHUNE;HERMAN AUGUSTINUS DE KOCK;ABDELLAH TAHRI;MONTSERRAT ERRA SOLA
分类号 A61K31/423;A61K31/427;A61K31/4439;A61K31/454;A61K31/496;A61P31/18;A61P35/00;A61P43/00;C07D263/58;C07D413/04;C07D417/12;C07D417/14;C07D493/04;(IPC1-7):C07D493/04 主分类号 A61K31/423
代理机构 代理人
主权项
地址